Pathway and mechanism of oxidative stress in Alzheimer's disease

Journal of Medical Colleges of PLA

Volumn 22, Issue 5, 2007, Pages 320-324

  Cai, Zhi you ^a   Yan, Yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Oxidative stress

Indexed keywords

EID: 77950213300     PISSN: 10001948     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1000-1948(07)60064-1     Document Type: Review

References (48)

1. Zafrilla P, Mulero J, Xandri JM, et al. Oxidative stress in Alzheimer patients in different stages of the disease [J]. Curr MedChem 2006, S13(9):1075.
2. Zhu X, Smith MA, Honda K, et al. Vascular oxidative stress in Alzheimer disease [J]. J Neural Sci 2007, 257(1-2):240.
3. Siegel SJ, Bieschke J, Powers ET, et al. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation [J]. Biochemistry 2007, 46(6):1503.
4. Mielke MM, Lyketsos CG Lipids and the pathogenesis of Alzheimer's disease: is there a link? [J]. Jnt Rev Psychiatry 2006, l8(2):U73.
5. Lauderback CM, Kanski J, Hackett JM, et al. Apolipoprotein E modulates Alzheimer's Abeta (l-42)-induced oxidative damage to synaptosomes in an allele-specific manner [J]. Brain Res 2002, 924(1):i90.
6. Lane RM, Farlow MR Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease [J]. J Lipid Res 2005, 46(5):949.
7. Smith DG, Cappai R, Barnham KJ The redox chemistry of the Alzheimer's disease amyloid beta peptide [J]. Biochim Biophys Acta 2007, 1768(8):1976.
8. Dietrich M, Hu Y, Block G, et al. Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans [J]. Lipids 2005, 40(4):329.
9. Galbusera C, Facheris M, Magni F, et al. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients [J]. Curr Alzheimer Res 2004, 1(2):103.
10. Arlt S, Beisiegel U, Kontush A Lipid peroxidation in neurode-generation: new insights into Alzheimer's disease [J]. Curr OpinLipidol 2002, 13(3):289.
11. Bassett CN, Montine TJ Lipoproteins and lipid peroxidation in Alzheimer's disease [J]. J Nutr Health Aging 2003, 7(9):24.
12. Yao Y, Clark CM, Trojanowski JQ, et al. Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment [J]. Ann Neural 2005, 58(4):623.
13. Busciglio J, Yankner BA Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro [J]. Nature 1995, 378(6559):776.
14. Molina-Holgado F, Hider RC, Gaeta A, et al. Metals ions and neurodegeneration [J]. Biometah 2007, 20(3-4):639.
15. Kaneko N, Sugioka T, Sakurai H Aluminum compounds enhance lipid peroxidation in liposomes: Insight into cellular damage caused by oxidative stress [J]. J Inorg Biochem 2007, 101(6):967.
16. Zheng H, Blat D, Fridkin M Novel neuroprotective neu-rotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases [J]. J Neural Transm 2006, 71(Suppl):163.
17. Arlt S, Kontush A, Muller-Thomsen T, et al. Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease [J]. Z Gerontol Geriatr 2001, 34(6):461.
18. He XM, Zhang ZX, Zhang JW, et al. Glnl92Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population [J]. Chin Med J (Engl) 2006, ll9(14):1204.
19. Kuhla B, Boeck K, Schmidt A, et al. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains [J]. Neurobiol Aging 2007, 28(1):29.
20. Sato T, Shimogaito N, Wu X, et al. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease [J]. Am J Alzheimer* Dis Other Demen 2006, 21(3):197.
21. Geroldi D, Falcone C, Emanuele E Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target [J]. Curr Med Chem 2006, 13(17):1971.
22. Huang Y, Liu F, Grundke-Iqbal I, et al. NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaB gamma, are both elevated in Alzheimer disease brain [J]. Neurosd Lett 2005, 373(8):115.
23. Kitamura Y, Shimohama S, Ota T, et al. Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains [J]. Neurosd Lett 1997, 237(1):17.
24. Du Yan S, Zhu H, Fu J, et al. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proin-flammatory pathway in Alzheimer disease [J]. Proc Natl Acad SciUSA 1997, 94(10):5296.
25. Boissiere F, Hunot S, Faucheux B, et al. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease [J]. Neuroreport 1997, 8(13):2849.
26. Gao F, Bales KR, Dodel RC, et al. NF-kappaB mediates IL-1 beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line [J]. Brain Res Mol Brain Res 2002, 105(1-2):108.
27. Chong ZZ, Li F, Maiese K Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity [J]. Curr Neu-rovasc Res 2005, 2(5):387.
28. Fiebich BL, Hofer TJ, Lieb K, et al. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-an-ti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha[J]. Neuropharmacology 1999, 38(9):1325.
29. Lezoualc'h F, Behl C Transcription factor NF-kappaB: friend or foe of neurons? [J]. Mol Psychiatry 1998, 3(1):15.
30. Yan SD, Chen X, Schmidt AM, et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress [J]. Proc Natl Acad SciUSA 1994, 91(16):7787.
31. Zhang YJ, Xu YF, Liu YH, et al. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms [J]. FASEB J 2006, 20(9):1431.
32. Sultana R, Perluigi M, Butterfield DA Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox pro-teomics [J]. Antioxid Redox Signal 2006, 8(11-12):2021.
33. Yan SD, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease [J]. Nature 1996, 382(6593):685.
34. Arancio O, Zhang HP, Chen X, et al. RAGE potentiates Abe-ta-induced perturbation of neuronal function in transgenic mice [J]. EMBOJ 2004, 23(20):4096.
35. Bayer TA, Schafer S, Breyhan H, et al. A vicious circle; role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease [J]. Clin Neuropathol 2006, 25(4):163.
36. Maurya OP, Mohanty L, Bhaduri G, et al. Role of anti-oxidant enzymes superoxide dismutase and catalase in the development of cataract: study of serum levels in patients with senile and diabetic cataracts [J]. J Indian Med Assoc 2006, 104(7):394.
37. Schipper HM, Bennett DA, Liberman A, et al. Glial heme oxy-genase-1 expression in Alzheimer disease and mild cognitive impairment [J]. Neurobiol Aging 2006, 27(2):252.
38. Song W, Su H, Song S, et al. Over-expression of heme oxyge-nase-1 promotes oxidative mitochondrial damage in rat astroglia [J]. J Cell Physiol 2006, 206(3):655.
39. Palmer AM, Burns MA Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease [J]. Brain Journal of Medical Colleges of PLA 2007, 22(5).
40. Filipcik P, Cente M, Ferencik M, et al. The role of oxidative stress in the pathogenesis of Alzheimer's disease [J]. Bratisl Lek Listy 2006, 107(9-10):384.
41. Gabbita SP, Lovell MA, Markesbery WR Increased nuclear DNA oxidation in the brain in Alzheimer's disease [J]. J Neu-rochem 1998, 71(5):2034.
42. Markesbery WR, Lovell MA DNA oxidation in Alzheimer's disease [J]. Antioxid Redox Signal 2006, 8(11-12):2039.
43. Flirski M, Sobow T Biochemical markers and risk factors of Alzheimer's disease [J]. Curr Alzheimer Res 2005, 2(1):47.
44. Lovell MA, Markesbery WR Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid [J]. Arch Neural 2001, 58(3):392.
45. Mancuso C, Scapagini G, Curro D, et al. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders [J]. Front Biosci 2007, 12:1107.
46. Nakabeppu Y, Kajitani K, Sakamoto K, et al. MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides [J]. DNA Repair (Amst) 2006, 5(7):761.
47. Jimenez-Jimenez FJ, Alonso-Navarro H, Ayuso-Peralta L, et al. Oxidative stress and Alzheimer's disease [J]. Rev Neural 2006, 42(7):419.
48. Liu Q, Xie F, Rolston R, et al. Prevention and treatment of Alzheimer disease and aging: antioxidants [J]. Mini Rev Med Chem 2007, 7(2):171.